Intellipharmaceutics (IPCI) Announces $1.8 Million Registered Direct Offering
Tweet Send to a Friend
Intellipharmaceutics International Inc. (NASDAQ: IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE